Document is current
Any future updates will be listed below
-
Authors
Wada, Hideo
Teranishi, Hirofumi
Shimono, Akihiko
Kato, Noritoshi
Maruyama, Shoichi
Matsumoto, Masanori
- License Information
-
More Information
Article History
Received: 25 January 2023
Accepted: 12 April 2023
First Online: 18 April 2023
Declarations
:
: PMS mandated by the Japanese health authority was conducted by post-marketing study good practice guidelines for drugs. Ethical approval by an institutional review board and informed consent from individual patients were non-mandatory for PMS.
: Not applicable.
: H.W. reports consulting fees from Alexion Pharma GK. M.M., N.K. and S.M. report payment for lectures and participation on advisory board from Alexion Pharma GK during the conduct of the study. H.T., A.S. are employees of Alexion Pharma GK and shareholders of Alexion Pharmaceutical Inc. during the conduct of the study.
